ArticleCase reports in endocrinology2019

A Case Report of Graves' Disease Induced by the Anti-Human Programmed Cell Death-1 Monoclonal Antibody Pembrolizumab in a Bladder Cancer Patient.

Ken Yajima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.